Solid-phase peptide synthesis, most commonly referred to as SPPS (solid-phase peptide synthesis), is a chemical method of building peptide chains from amino acid to amino acid, while one end of the resulting chain remains chemically linked to an insoluble carrier.
Instead of isolating the resulting peptide after each reaction, chemists leave it attached to the solid phase, introducing and removing successive liquid reagents and wash solutions. The repeated cycles allow the reactive amino group to be exposed, another amino acid to be attached, and the soluble components that are no longer needed to be removed. After the planned amino acid sequence has been built, the peptide can be removed from the carrier and then subjected to further processing and analysis.
Such a process organization is one of the main reasons why SPPS has become such an important method in peptide chemistry. The fixed phase simplifies the execution of many repetitive chemical operations and enabled the automation of synthesis.
The convenience of synthesis at the constant phase does not, however, guarantee chemical perfection.
Joining the emerging peptide to the carrier does not guarantee that each chain will receive all the planned amino acids. It also does not mean that the material released at the end of the process will be chemically pure or have a correct structure.
Chain assembly, de-bonding and reclaiming the product, purification, identity confirmation, and final structural characterization are separate parts of the entire process.
Contemporary methodological publications demonstrate both the usefulness of SPPS and the need to modify standard methods in the case of difficult sequences. In one of the published methods using the Fmoc strategy, for example, a routine synthesis is described, but also a modified approach to peptide sequences prone to aggregation. [1]
Understanding SPPS therefore requires more than memorizing the subsequent chemical steps. It is also necessary to know what the goal of each step is, what can go wrong during it, and what analytical questions still need to be answered after its completion.
What is peptide synthesis in the solid phase?
The emerging peptide remains attached, and the solutions change
In conventional SPPS, the peptide is chemically attached to small insoluble particles, usually called resin granules, using an appropriate chemical linker.
The grains remain in the reaction system, while subsequent liquid reagents and wash solutions are introduced and removed.
This greatly simplifies the repetitive synthesis.
In classical, batch synthesis, isolating and purifying the growing peptide after each addition of an amino acid can be cumbersome. In SPPS, the resulting chain remains bound to the insoluble phase. This allows soluble excess reagents and many byproducts to be removed by washing, while the peptide bound to the resin remains in place.
The term „stationary phase” can, however, lead to misunderstandings.
This does not mean that peptide bonds are formed without the involvement of a solvent or a liquid.
The resin is usually surrounded by a liquid reaction medium, and its interaction with the solvent can significantly influence the course of the synthesis. The reagents must still move in or around the polymer environment and reach the reactive sites of the growing peptide.
The attachment of a peptide to a carrier is usually of a covalent nature. This means that the resulting molecule is linked to the carrier through a linker using a chemical bond.
The peptide is therefore not simply trapped between particles, held by a filter, or loosely deposited on the surface.
Such chemical combination is deliberately designed in such a way that the resulting chain remains bound during subsequent reactions and washing stages, and can subsequently be released under appropriate conditions.
Conventional synthesis proceeds from the C-terminus towards the N-terminus
Classical linear SPPS strategy usually starts with an amino acid that will form the C-terminus of the finished peptide.
The rest is attached to the carrier.
After the appropriate reactive amino group has been introduced, another protected amino acid is added and chemically attached to the resulting chain. This process of repeated addition gradually elongates the peptide towards the N-terminus.
It is worth highlighting this direction, because it differs from biological protein synthesis via ribosomes.
Ribosomal synthesis extends the polypeptide from the N-terminus towards the C-terminus. Conventional step-wise SPPS usually builds the sequence in the opposite direction.
However, the final sequence of amino acids may be identical. The way it is built is different.
It is important to specify „conventional” here, because peptide chemistry also includes specialized strategies that utilize alternative attachment sites, fragment assembly, ligation reactions, and other non-standard solutions.
The description of the route from the C-terminus to the N-terminus therefore refers to a typical sequential SPPS process, and not to all possible methods of peptide chemistry that utilize the solid phase.
SPPS is only one of the components of peptide production
Solid-phase synthesis is not the only way to obtain peptides.
Peptides can also be obtained through chemical synthesis in solution, biological expression systems, enzymatic transformations, fragment ligation, or combinations of different methods.
SPPS is particularly useful when controlled sequence assembly and the use of protected, modified, or otherwise specialized amino acid building blocks are required.
Even within a single project involving a specific peptide, it is not always necessary to use the same method from start to finish.
Individual fragments of a peptide can, for example, be synthesized on a resin, purified separately, and then combined by another chemical method. Other molecules may require folding, oxidation, cyclization, or additional structural modifications after the initial linear sequence has been obtained.
The choice of the appropriate route therefore depends on the target molecule, its structural complexity, and the analytical and quality requirements of the project.
The process is worth considering as a series of consecutive questions.
Attachment to the carrier marks the starting point and influences the subsequent chemical release of the product. However, it still needs to be determined whether the attachment occurred correctly and whether the stereochemical integrity was maintained.
The chain assembly process is intended to link amino acids in the planned order. However, it is necessary to check whether all the chains have reacted correctly and whether sequences containing missing amino acids, truncated or modified products, have not formed.
Disgassing and removing the protective groups are intended to release the peptide and remove certain chemical protections. However, the actual effective release of the product does not tell us what other substances are present in the raw material.
Purification serves to separate the desired material from the undesirable components, but even the purified fraction still requires confirmation of identity and quality assessment.
The final structural and analytical characterization, on the other hand, is intended to answer the question of whether the isolated material has the chemical properties expected for the target peptide and whether the analytical methods used are appropriate for the intended application.
These are conceptual steps, not a laboratory instruction. The specific reagents, apparatus, and reaction conditions depend on the target peptide and require an appropriately developed and validated method.
Joining the resin and assembling the chain
Resin, binder and primer level perform different functions
In discussions about SPPS, three terms often appear: resin, binder, and the degree of loading, or loading.
They describe related but different properties.
The resin is an insoluble material that serves as a carrier.
The linker provides a chemical bond between this carrier and the peptide or the first amino acid residue. Its chemistry can influence both the way the peptide is attached and its subsequent release.
Loading, on the other hand, describes the number of reactive connection points relative to the amount of media.
These terms are not synonyms.
Two resins can look physically very similar while having different functional groups, linkages, or degree of substitution. These differences can affect the availability of reactive sites during chain assembly, the crosslinking of the resin, and the chemical form of the final peptide after cleavage.
The next important element is the planned group at the C end.
Different carrier-linker systems can be selected, for example in such a way as to obtain a peptide terminated by a carboxyl or amide group.
This is an important chemical difference.
Changing the terminal group means changing the molecule itself, not just the way it is packaged or described.
The entanglement affects access to the connected chains
Many of the solvents used in SPPS absorb the solvent and swell upon contact with the appropriate liquid medium.
This changes the polymer environment and can increase or decrease the space through which dissolved reagents must move to reach the peptide chains associated with the resin.
Stretching is therefore not just a physical curiosity.
It may affect the availability of reactive groups during synthesis.
A systematic study of polystyrene and PEG-based carriers showed that properties such as the type of linker and the degree of resin grafting significantly influenced swelling in the more environmentally friendly solvents tested. It was also found that swelling can change during removal of protective groups and as the peptide chain lengthens. [2]
This shows that the behavior of a resin cannot always be considered its constant property.
In practice, it depends on the interaction of the resin, the solvent, the linker, the attached peptide, and the current stage of synthesis.
A good cross-linking or a favorable reaction course for one combination of resin, solvent, and peptide does not mean that another combination will behave identically.
The connection itself also requires quality control
The first stage of attachment may seem simple, because the peptide chain is just beginning to form.
However, an error introduced at this stage may remain present during all subsequent synthesis.
If the first residue is attached incorrectly or its stereochemistry changes during this process, the correct addition of all subsequent residues does not necessarily fix the initial problem.
In a 1992 study, an analytical method was developed specifically for measuring racemization occurring during the attachment of protected amino acids to solid carriers.[3]
The significance of this work goes beyond the analytical method itself.
It shows that stereochemical quality may require control even before the repeated chain-elongation cycles begin.
The amount of material initially attached to the carrier also requires proper interpretation.
The nominal degree of resin loading, the experimentally measured loading, the amount of raw material recovered after separation, and the final yield of the isolated and purified peptide are different quantities.
They should not be treated as surrogate indicators of the success of synthesis.
Longer chains may become more difficult to obtain
As the peptide chain lengthens, the individual molecule itself begins to influence its chemical environment.
Neighboring chains can interact with each other through hydrogen bonds, hydrophobic interactions, and other intermolecular forces. Some sequences may exhibit a particularly strong tendency to such interactions.
This may limit access to reactive groups.
In such a situation, the addition of another amino acid can become more difficult, even if a seemingly sufficient amount of the coupling agent has been introduced into the system.
A study on difficult, aggregable sequences compared different linkage methods and analyzed the resulting raw products. The results support the principle that the process should be adapted to the specific sequence, rather than assuming the existence of a single linkage strategy that is always the best. [4]
This also explains why simply increasing the degree of polymerization of the resin or the amount of the activator does not automatically solve all problems.
If the primary problem is limited access to reactive sites, the question of whether the added reagent has indeed reached the appropriate sites and whether the reaction has taken place efficiently without the formation of unacceptable amounts of by-products becomes more important than the quantity of reagent added.
Security, removal of protection groups and pairing
Security groups are monitoring the reaction site
Amino acids contain chemical groups capable of participating in various reactions.
During controlled peptide synthesis, chemists usually want a specific amino group to react with a specific block containing a carboxyl group, while other potentially reactive sites remain temporarily inactive.
This is exactly what security groups are for.
They temporarily block selected reactive sites, allowing another site to participate in the planned reaction.
In the commonly used SPPS strategy based on Fmoc, the final amino group of the growing chain remains protected between the subsequent joining steps. When the next amino acid is to be joined, the temporary protection is removed, revealing the amino group.
Reactive side chains can have separate protective groups designed so that they remain intact during repeated cycles of building the main chain.
The goal is controlled selectivity.
The appropriate block containing the carboxyl group should combine with the appropriate amino group, rather than leading to uncontrolled branching or other competing reactions.
Orthogonality means the possibility of selectively removing security measures
The orthogonal strategy of protective groups allows one protective group to be removed under conditions where the other necessary safeguards remain sufficiently intact.
This gives the chemist the ability to selectively expose different reactive sites during the various stages of synthesis.
Fmoc and Boc are well-known terms in peptide chemistry, but they do not denote different types of peptide bonds or different end structures of a peptide.
These are protective groups related to different synthesis strategies and different methods of their removal.
The temporary chemical pathway used during peptide construction should therefore be distinguished from its final structure.
The precautions also do not provide full protection against all possible side effects.
Studies on the formation of aspartimide, for example, show that the stabilization strategy, neighboring amino acid residues, and the conditions for removing protective groups can influence the formation of impurities even in well-known SPPS methods.[5][6]
The protective group strategy therefore limits certain undesirable reactions, but does not eliminate the need for process control or final analytical characterization.
Joining creates another amide bond in the peptide backbone
The binding reaction leads to the formation of another amide bond in the peptide backbone.
The amino acid block containing the carboxyl group is usually chemically activated so that it can effectively react with the exposed amine group of the growing peptide attached to the substrate.
After the coupling is complete, the soluble excess material can be removed by washing.
The newly added amino acid then becomes the final residue of the growing chain. Subsequently, its amino group can be exposed and another pairing cycle can begin.
Theoretically, repeating this sequence allows the order of amino acids to be controlled by controlling the order in which building blocks are introduced.
In practice, however, there is a very important caveat:
The planned chemical reaction must indeed run correctly in each cycle.
If one pairing is incomplete, part of the chains may not receive the planned portion.
If they remain attached to the resin and react properly in the next cycle, they can form delection sequences, that is, peptide molecules devoid of one or more planned amino acids.
Other chains may remain shortened.
The washing process removes soluble reagents and byproducts, but it does not selectively eliminate all the incorrectly constructed chains that are still covalently bound to the carrier.
Small losses can accumulate over many cycles
The repetitive nature of SPPS leads to a significant mathematical problem.
A minor imperfection in a single stage may seem insignificant, but after many repetitions its effects can accumulate.
Let us consider a simple mathematical example.
If the synthesis of a peptide required 50 stages of coupling, and each of them had independently a probability of 99% of a correct outcome, the theoretical percentage of molecules that would successfully undergo all 50 stages would be approximately 60.5%.
This is just an illustration.
It assumes that all stages behave identically and independently. It does not account for problems with removing protective groups, side reactions, losses during deprotection and purification, aggregation, or many other real factors.
Therefore, this result should not be interpreted as a prediction of actual production performance.
The example shows only why even very high performance of individual steps does not guarantee a chemically simple raw product after several dozen repetitions.
Therefore, monitoring of synthesis and control of impurities are important during the entire peptide synthesis process, and not only after the addition of the last amino acid.
Automation, heating and other technological solutions can speed up the synthesis process, but the speed of the process should always be evaluated in conjunction with the quality of the product.
The study of SPPS assisted by microwaves analyzed the racemization and the formation of aspartimide depending on the type, showing why the reaction conditions still need to be adapted to the properties of the specific sequence.[7]
Separation and recovery of the raw product
Disassembly releases the product from the carrier
After the planned peptide sequence has been constructed, it is usually chemically separated from the carrier.
This stage is referred to as cleavage, or debranching.
Degradation interrupts the intentionally designed chemical bond between the peptide and the carrier.
Depending on the strategy employed, detachment can occur simultaneously with the removal of part or all of the protective groups of the side chains. In other processes, the peptide or its fragment can be released while retaining some of the protective groups if further chemical modifications are planned.
The appropriate release chemistry depends on the linker and the target molecule.
Conditions that effectively release one peptide can chemically damage the chemically sensitive group in another.
Therefore, dephosphorylation describes a specific chemical target, rather than a universal set of reagents or conditions suitable for all peptides.
Similarly, the correct structure of the peptide backbone does not prove that all the protective groups were subsequently effectively removed.
The assembly of the chain and the final removal of the safeguards address different chemical questions and require a separate assessment.
Conditions of de-polluting can affect the pollution profile
De-pigmentation does not have to be a chemically indifferent step.
Removing protective groups and breaking the peptide-carrier bond can lead to the formation of reactive chemical forms capable of modifying the peptide or other components of the mixture.
Therefore, the so-called scavengers can be used in the developed methods, which are compounds that capture certain undesirable reactive products and influence the formation of byproducts.
A 2019 study analyzed various scavengers during the removal of exenatide from a peptide resin and showed that their selection influenced the quality of the crude product and the observed contaminant profile.[8]
On this basis, it is not necessary to create a universal recipe for de-escalation.
The study shows, however, that the conditions of this stage can affect the quality of the product and should therefore be evaluated for the specific peptide and the protective group system used.
The proper de-coupling process therefore has several dimensions.
The peptide must be properly cleaved, the required protective groups must be removed, the target material must be recovered, and undesirable chemical transformations must be controlled.
Recovering the raw product is not the final purification process
After separation, a process is carried out to separate the material containing the peptide from the solid resin and the remaining components of the reaction mixture.
This can be used to exploit differences in solubility, volatility, or other chemical properties.
However, the recovery of visible sediment or a peptide-containing fraction does not prove that the material consists solely of the intended product.
At this stage, we usually talk about a crude peptide.
It can contain the target molecule along with deletion sequences, shortened chains, chemically modified peptides, incompletely deprotected structures, reagents-derived materials, and other impurities.
The significance of individual pollutants depends on the sequence, synthesis conditions, and intended use.
In one study, a chromatographic separation was combined with mass spectrometry to characterize the crude SPPS products and assign individual chromatographic peaks to the specific peptides. [9]
This shows why the information obtained through separation and structural methods complement each other.
Chromatography can reveal the presence of many components, while mass spectrometry can provide additional information that helps determine what some of them may be.
Clearing and confirming identity answer different questions
Purification aims to enrich or isolate the target molecule from other components.
Identification, on the other hand, answers the question of whether the isolated material actually has the expected chemical properties.
These questions overlap to some extent, but they are not the same thing.
A well-resolved chromatographic peak does not automatically provide a complete proof of the structure of the molecule.
Similarly, obtaining the expected molecular mass by itself is not a complete assessment of purity or structural correctness.
Closely related variants of sequences, stereoisomers, or chemically modified forms may be difficult to distinguish or separate.
The purification method should therefore be evaluated with respect to the actual mixture produced during a given synthesis, and not considered sufficient simply because it has proven effective in the case of another peptide.
If the final molecule also requires the formation of disulfide bridges, cyclization, or other transformations after the chain has been assembled, further analytical questions arise regarding the correctness of the bonds, structural homogeneity, and whether the intended mature form of the molecule has indeed been obtained.
Advantages, limitations and sources of pollution
Why is SPPS so widely used?
One of the most important advantages of SPPS is the ability to maintain the resulting peptide on a carrier during repeated exchanges of liquid reagents.
This simplifies repetitive chemical operations and enables automation.
Chemists can introduce a planned sequence of amino acid building blocks, and if the process chemistry allows, also some non-standard amino acids and other modifications.
Modern automated systems show how far this concept can be developed.
A study on automated flow synthesis from 2020 described the production of protein chains containing up to 164 amino acid residues. After subsequent purification and folding, functional materials were obtained.[10]
This is an impressive example of technical possibilities.
However, this does not mean that every sequence of 164 residues — nor every long peptide or protein — can be obtained with the same ease.
It also does not mean that purification and structural characteristics become unnecessary.
The study shows rather what results can be achieved with a carefully designed system for appropriately selected molecules.
Automation controls the execution of the process.
However, it is unable to convert inappropriate chemistry into appropriate one.
Therefore, the performance of the apparatus, the peptide sequence, and the behavior of the molecule itself must be analyzed together.
How do typical pollutants form?
During SPPS, several different pathways can occur leading to the formation of pollutants. Understanding them helps explain why final analytical studies are still necessary.
A degenerate sequence or a truncated product can arise when the intended amino acid addition does not succeed or when the chain elongation is interrupted. Because the incorrect chain can still remain attached to the resin, subsequent washing may not remove it.
Epimerization means a change in the stereochemical configuration of the corresponding center. This has particular analytical significance because an epimer can have the same nominal molecular mass as the corresponding peptide, while at the same time having a different spatial configuration.
Products related to aspartame can be formed as a result of side reaction sequences that involve the aspartic acid residues. Depending on the chemical pathway, more than one type of such product can be formed.
Incomplete removal of protective groups occurs when the group that should be removed remains bound to the molecule. The peptide may therefore have the nominally expected chain length, but still possess an incorrect chemical structure.
Modifications related to deprotection may occur during the final peptide release or removal of protective groups. Therefore, proper chain formation does not guarantee that the peptide will undergo the deprotection step without any changes.
Incomplete aggregation reactions can, however, occur when the resulting chains interact in a way that restricts access to the reactive sites. Introducing sufficient amount of reagent into the reaction vessel does not guarantee that each reactive site is physically accessible and undergoes the appropriate reaction.
These are possible routes of pollutant formation.
This does not mean that every party received through the SPPS method must contain all the types of irregularities mentioned above.
Their significance in a specific synthesis is determined based on process knowledge, analytical research, and appropriate quality control.
Natural peptides require more than just recreating the sequence
Some peptides are structurally much more complex than would be inferred from the linear sequence of amino acids alone.
A good example is epidermine.
The structural characteristics of the epidermis showed the presence of many sulfur-containing rings and atypical residues.[11]
Therefore, simply reproducing the linear sequence of amino acids would not be sufficient evidence that an authentic mature epidermine was obtained.
This distinction is important when interpreting publications or searches regarding the synthesis of the epidermis at the steady-state phase.
The publication may describe a linear precursor, fragment, analog, or other related structure, rather than the verified complete synthesis of a complete mature molecule.
The structural publication cited here as [11] describes the characteristics of the epidermis itself; it is not a report on its total synthesis using the SPPS method.
Claims about total synthesis should therefore be evaluated with respect to the actual target structure of the molecule, and not solely its linear amino acid sequence.
Performance, purity and identity must be presented separately
Three concepts often confused in discussions about peptide synthesis are yield, purity, and identity.
The large amount of recovered product does not necessarily mean that most of this material is intended peptide. The raw material may contain significant amounts of impurities.
Similarly, high chromatographic purity does not automatically confirm all aspects of structural identity.
Even a peptide whose chemical structure has been precisely characterized does not automatically obtain confirmed biological, therapeutic, or clinical use.
These are separate issues.
A reliable description of the synthesis should therefore indicate what the target molecule was, at what stage the yield was measured, whether the material under analysis was crude or purified, and what analytical data were used to confirm the claims regarding the structure.
Thanks to this, the results of the synthesis can be interpreted and compared in a more reliable way.
A single percentage value or mass value should not be transformed into a general statement that a peptide is „of high quality” without knowledge of what was actually measured.
Frequently asked questions
1. Why is a fixed phase used in SPPS?
The stationary phase retains the nascent peptide on the carrier, while soluble reagents, byproducts of the reaction, and wash solutions can be repeatedly introduced and removed. This greatly simplifies repeated chain assembly and enables the automation of peptide synthesis, exemplified by modern flow-based automated synthesis methods.[10] However, the carrier does not guarantee that every reaction will run perfectly, nor does it separate an incorrectly constructed chain attached to the resin from the correct one. Its primary advantage is in streamlining the process. Chemical selectivity, reaction completeness, purity, and structural identity still require separate evaluation.
2. Does the synthesis at the solid phase eliminate the need for purification?
No. Abnormal peptide chains can remain attached to the resin during synthesis and then be released together with the intended product. Studies analyzing crude SPPS using chromatography and mass spectrometry show that washing during synthesis and final purification perform different functions. [9] Washing removes primarily the soluble components surrounding the resin, whereas post-decoupling purification is intended to separate the desired peptide from the unwanted peptide and non-peptide components. SPPS simplifies intermediate operations but does not guarantee ultimate purity.
3. Does the „solid phase” mean that a solvent is not used?
No. In conventional SPPS, the insoluble carrier is usually surrounded by liquid reagents and solvents. Solvents affect the physical environment of the resin, including the degree of its swelling and the ease with which reagents can reach the attached chains. Experimental studies have shown solvent-dependent swelling of resins and changes related to the chemistry of the linker, the degree of crosslinking, and chain elongation.[2] The resin and solvent thus form a reaction environment together.
4. In which direction does the peptide grow during SPPS?
Conventional stepwise SPPS usually builds the peptide from its C-terminus towards the N-terminus. The first amino acid that is to form the C-terminus of the finished molecule is attached to the carrier, and subsequent residues extend the exposed amino acid chain end. Published methods based on Fmoc show this typical pattern.[1] However, there are specialized solid-phase strategies that can proceed differently.
5. Do resin and connector mean the same thing?
No. The resin is an insoluble carrier, whereas the linker is a chemical bond between the carrier and the growing peptide. The functionality of the linker can independently of the polymer itself influence the attachment, the retention of the resin, and the subsequent release of the peptide. Studies of carriers used in peptide synthesis show why the term of the resin itself may not be sufficient to describe the behavior of the entire system.[2]
6. Does a higher degree of resin grafting always increase production?
No. Higher loading means a greater number of potential attachment sites per unit volume of carrier, but this does not necessarily lead to a greater amount of properly formed and recoverable peptide. The degree of attachment can alter the local molecular environment and has been experimentally indicated as one of the factors influencing the swelling of the resin. [2] If the attached chains are excessively crowded or strongly interacting with each other, the availability of reactive sites may deteriorate. Loading should therefore be analyzed in conjunction with the properties of the resin, sequence behavior, reaction yield, and the quality of the final product.
7. Why are amino acids protected during peptide synthesis?
Protective groups temporarily prevent selected reactive groups from participating in reactions while a specific bond is being formed. This allows for controlled, stepwise chain assembly. However, protection does not eliminate all side reactions. Studies on model systems have shown, for example, that the protective group strategy and the surrounding sequence can influence the formation of aspartimide.[5] Protective groups therefore provide chemical selectivity, but the entire protection and deprotection strategy still requires careful planning and evaluation.
8. What does orthogonal protection of functional groups mean?
Orthogonality means the ability to remove one protective group under conditions that leave other necessary protections sufficiently intact. This allows specific reactive sites to be revealed at the planned stages of synthesis. Established SPPS methods rely on controlled protection and deprotection instead of simultaneously revealing all reactive groups.[1] However, the actual compatibility of the applied protections still depends on the target molecule and the reaction conditions.
9. Do Fmoc and Boc denote different types of peptides?
No. Fmoc and Boc are protective groups and related synthetic strategies, not different types of peptide backbone. Differences in the chemistry of their removal affect the way synthesis is conducted, but temporary protective chemistry should not be confused with the final structure of the target peptide. The published methods based on Fmoc demonstrate one of the commonly used SPPS variants, but this does not mean that every peptide must be obtained using this method. [1]
10. Can the first stage of connection already cause pollution?
Yes. The attachment step can affect stereochemical quality even before the multiple chain extension begins. Analytical methods designed specifically to detect racemization during the attachment of protected amino acids to resins have been developed.[3] This does not mean that every attachment causes significant racemization. It does indicate that the attachment itself is a chemically significant step during which measurable changes may occur that require consideration in the overall quality assessment.
11. Why are some peptide sequences considered difficult?
Some growing peptide chains interact with one another or with neighboring chains in a manner that restricts access to reactive sites. Hydrogen bonds, hydrophobic interactions, and aggregation-like behaviors can hinder subsequent binding. Studies of aggregation-prone sequences show that changing the binding mode can affect the composition of the crude product.[4] The difficulty of synthesis therefore depends on the properties of the molecule and the reaction conditions, rather than solely on the length of the peptide.
12. Does faster synthesis always mean a better product?
No. The synthesis rate and product quality are separate parameters. Heating, microwave assistance, and automation can shorten the process time, but accelerating the reaction can also change the balance between desired and side reactions. Studies of microwave-assisted synthesis have shown a dependence on the type of residual racemate and the formation of aspartimide, indicating the need for appropriate control of the conditions. [7] A shorter synthesis time is beneficial only when the obtained material also meets the required chemical and analytical criteria.
13. Does degumming simply mean removing the resin grains?
No. Degumming is a chemical process that results in the breaking of the designed bond between the peptide and the carrier. Removal of the resin grains by filtration, however, is an operation that physically separates the material and in itself does not confirm the correct course of the degumming chemistry. The release of the peptide can occur simultaneously with the removal of protective groups and other reactions. Studies of scavengers used during degumming show that this step can affect the pollutant profile.[8]
14. Does high yield of crude product mean high purity of peptide?
No. The yield describes the amount of recovered material before removing all unwanted components. This material may contain the target peptide along with deletion sequences, modified structures, remaining protective groups, and other impurities. Studies of crude SPPS mixtures using chromatography and mass spectrometry show why the recovered mass, purity, and molecular identity require separate interpretation.[9] Therefore, a reliably reported yield should indicate the step at which it was measured and whether the material had already been purified.
15. Does SPPS allow receiving long peptide chains?
Yes. Carefully designed SPPS methods can enable the production of very long chains. In studies of automated flow synthesis, chains containing up to 164 residues were obtained, which were then purified and folded before functional evaluation. [10] This demonstrates the capabilities of modern peptide synthesis, but does not mean that every sequence of similar length can be obtained with the same yield. Length is only one factor; aggregation dependent on sequence, side reactions, folding requirements, and purification difficulty also play a role.
16. Does the construction of the epidermis sequence mean the complete synthesis of the epidermis?
No. Mature epidermis contains atypical structural elements, including sulfur-containing rings that go beyond the linear sequence of amino acids. This has been demonstrated in structural studies.[11] Obtaining a linear sequence, precursor, or fragment does not therefore automatically mean the synthesis of a complete mature molecule. The claim of complete synthesis requires analytical data confirming the replication of the intended bonds and other essential structural elements.
17. Does the expected molecular mass confirm the full correctness of the structure?
No. Obtaining the expected molecular mass provides valuable information, but the mass alone does not confirm all aspects of the peptide structure and does not exclude all relevant impurities. Two molecules can have the same nominal mass while having different stereochemistry or specific structural arrangement. Studies involving the separation of epimeric peptides show why stereochemical differences may require analytical methods capable of distinguishing structures that cannot be distinguished solely by mass measurement. [12] The final characterization should therefore be designed with realistic impurities and alternative structures that may arise during a particular synthesis in mind.
Summary
The synthesis of peptides at the solid phase has changed the chemistry of peptides, enabling the growth of the chain on an insoluble carrier during repeated introduction, reaction, and removal of soluble reagents. This facilitates sequential building of the sequence and provides a practical basis for automatic synthesis.
The apparent simplicity of this method should not, however, mislead about the chemistry occurring at each stage.
The resin, linker, and degree of substitution influence the important properties of the synthesis environment. Solvent-dependent crosslinking affects the accessibility of the resin-related chains. Protective groups control which functional groups can react, whereas binding reactions build the peptide backbone from residue to residue.[1][2]
Each of these stages also has its limitations.
Initial coupling can affect stereochemistry. [3] Complex sequences can aggregate and limit the availability of reagents. [4] The chemistry of protecting and removing groups can favor side reactions such as the formation of aspartimide. [5] [6] Accelerated synthesis conditions can alter the degree of racemization or the profile of impurities. [7] Separation conditions can additionally affect the composition of the crude product. [8]
Therefore, the correct construction of the chain is not synonymous with obtaining a pure and properly identified peptide.
Purification of the crude product, purification, and structural characterization remain separate steps. Chromatography can provide information about the composition of the mixture and purity, whereas mass spectrometry and other analytical methods provide information about identity. No single analytical result needs to confirm all aspects of the peptide structure.[9][12]
Modern automated flow synthesis shows that under appropriately designed conditions SPPS can be applied even to very long chains. [10] At the same time, structurally complex peptides such as epidermin show why the self-assembly of a linear amino acid sequence may not be sufficient if the mature molecule contains additional rings, unusual residues, or a specific arrangement of bonds. [11]
It is best to understand SPPS not as a single reaction, but as a sequence of separate chemical and analytical stages.
The attachment marks the starting point. The repeated cycles of securing, unlocking, and connecting build the planned chain. Disbonding releases the product. Cleaning separates the target molecule from unwanted components. The final characterization then allows determining whether the isolated material actually has the structure and quality attributed to it.
Separating these stages avoids several common misunderstandings: successful synthesis does not automatically confirm purity, high yield does not automatically confirm identity, and the expected molecular mass by itself does not prove full structural correctness.
References
- Coin, I., Beyermann, M., & Bienert, M. (2007). Solid-phase peptide synthesis: From standard procedures to the synthesis of difficult sequences. Nature Protocols, 2(12), 3247–3256. https://doi.org/10.1038/nprot.2007.454
- Amadi-Kamalu, C., Clarke, H., McRobie, M., Mortimer, J., North, M., Ran, Y., Routledge, A., Sibbald, D., Tickias, M., Tse, K., & Willway, H. (2020). Investigation of parameters that affect resin swelling in green solvents. ChemistryOpen, 9(4), 431–441. https://doi.org/10.1002/open.202000030
- Adamson, J. G., Hoang, T., Crivici, A., & Lajoie, G. A. (1992). Use of Marfey’s reagent to quantitate racemization upon anchoring of amino acids to solid supports for peptide synthesis. Analytical Biochemistry, 202(1), 210–214. https://doi.org/10.1016/0003-2697%2892%2990229-z
- Caporale, A., Doti, N., Sandomenico, A., & Ruvo, M. (2017). Evaluation of combined use of Oxyma and HATU in aggregating peptide sequences. Journal of Peptide Science, 23(4), 272–281. https://doi.org/10.1002/psc.2977
- Mergler, M., Dick, F., Sax, B., Weiler, P., & Vorherr, T. (2003). The aspartimide problem in Fmoc-based SPPS. Part I. Journal of Peptide Science, 9(1), 36–46. https://doi.org/10.1002/psc.430
- Mergler, M., Dick, F., Sax, B., Stähelin, C., & Vorherr, T. (2003). The aspartimide problem in Fmoc-based SPPS. Part II. Journal of Peptide Science, 9(8), 518–526. https://doi.org/10.1002/psc.473
- Palasek, S. A., Cox, Z. J., & Collins, J. M. (2007). Limiting racemization and aspartimide formation in microwave-enhanced Fmoc solid phase peptide synthesis. Journal of Peptide Science, 13(3), 143–148. https://doi.org/10.1002/psc.804
- Pawlas, J., Svensson, T., & Rasmussen, J. H. (2019). 1,4-Benzenedimethanethiol (1,4-BDMT) as a scavenger for greener peptide resin cleavages. RSC Advances, 9(67), 38928–38934. https://doi.org/10.1039/c9ra08553j
- McKellop, K., Davidson, W., Hansen, G., Freeman, D., & Pallai, P. (1991). The characterization of crude products from solid-phase peptide synthesis by mu-HPLC/fast atom bombardment mass spectrometry. Peptide Research, 4(1), 40–46. PubMed
- Hartrampf, N., Saebi, A., Poskus, M., Gates, Z. P., Callahan, A. J., Cowfer, A. E., Hanna, S., Antilla, S., Schissel, C. K., Quartararo, A. J., Ye, X., Mijalis, A. J., Simon, M. D., Loas, A., Liu, S., Jessen, C., Nielsen, T. E., & Pentelute, B. L. (2020). Synthesis of proteins by automated flow chemistry. Science, 368(6494), 980–987. https://doi.org/10.1126/science.abb2491
- Allgaier, H., Jung, G., Werner, R. G., Schneider, U., & Zähner, H. (1986). Epidermin: Sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic. European Journal of Biochemistry, 160(1), 9–22. https://doi.org/10.1111/j.1432-1033.1986.tb09933.x
- Miyazawa, T., Otomatsu, T., Yamada, T., & Kuwata, S. (1992). Studies of racemization in peptide synthesis through the separation of protected epimeric peptides by reversed-phase high performance liquid chromatography. International Journal of Peptide and Protein Research, 39(3), 229–236. https://doi.org/10.1111/j.1399-3011.1992.tb00794.x